This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Neostem Inc
NBS : NASDAQ : Health Care
$6.17 | %
Today's Range: 6.00 - 6.32
Avg. Daily Volume: 313,300
07/25/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
NBS NEOSTEM INC 5.73 194.37 n/m 16.20 23.84
CCXI CHEMOCENTRYX INC 5.56 240.48 n/m 4.13 -34.69
KMDA KAMADA LTD 6.62 238.06 n/m 71.21 465.36
IDRA IDERA PHARMACEUTICALS INC 2.54 209.40 n/m 0.04 -12.25
PSTI PLURISTEM THERAPEUTICS INC 2.92 198.30 n/m 0.38 -44.53
TKMR TEKMIRA PHARMACEUTICALS CORP 8.98 198.25 n/m 17.93 40.72
AGEN AGENUS INC 2.94 182.97 n/m 2.66 -28.10
CYTR CYTRX CORP 3.22 179.60 n/m 0.30 200.00
BTX BIOTIME INC 2.35 169.55 n/m 4.89 26.11
CYTX CYTORI THERAPEUTICS INC 2.04 162.19 n/m 9.87 -41.16
BSTC BIOSPECIFICS TECHNOLOGIES CP 25.28 161.67 37.18 13.25 5.66
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

NBS Ind Avg S&P 500
n/m 52.05 19.42
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs